搜尋





搜尋





市場行情
/
股票
/
clgn
/

Collplant Biotechnologies Ltd

CLGN

添加自選

0.299USD

-0.001-0.30%

收盤 07-31 16:00（美東）報價延遲15分鐘

3.82M總市值

虧損本益比TTM

Collplant Biotechnologies Ltd

0.299

-0.001-0.30%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

CLGN 利潤表

您可以在這裡找到Collplant Biotechnologies Ltd的年度或季度收入報告，以深入了解Collplant Biotechnologies Ltd的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

營業總收入

-96.45%73.00K

-63.41%60.00K

1825.00%77.00K

-28.11%179.00K

1996.94%2.06M

-45.15%164.00K

-90.70%4.00K

-97.55%249.00K

-77.37%98.00K

415.52%299.00K

-60.55%43.00K

15330.30%10.18M

556.06%433.00K

-81.29%58.00K

-22.14%109.00K

-90.45%66.00K

-99.54%66.00K

-44.34%310.00K

-96.62%140.00K

-16.04%691.00K

2280.95%14.50M

26.88%557.00K

510.90%4.15M

35.81%823.00K

2.53%609.00K

--439.00K

--679.00K

--606.00K

--594.00K

營業收入

-96.45%73.00K

-63.41%60.00K

1825.00%77.00K

-28.11%179.00K

1996.94%2.06M

-45.15%164.00K

-90.70%4.00K

-97.55%249.00K

-77.37%98.00K

415.52%299.00K

-60.55%43.00K

15330.30%10.18M

556.06%433.00K

-81.29%58.00K

-22.14%109.00K

-90.45%66.00K

-99.54%66.00K

-44.34%310.00K

-96.62%140.00K

-16.04%691.00K

2280.95%14.50M

26.88%557.00K

510.90%4.15M

35.81%823.00K

2.53%609.00K

--439.00K

--679.00K

--606.00K

--594.00K

主營業務成本

68.09%316.00K

-29.41%192.00K

-1.10%269.00K

-65.30%186.00K

-65.50%188.00K

-64.81%272.00K

-2.16%272.00K

-12.85%536.00K

67.69%545.00K

1146.77%773.00K

5.30%278.00K

1330.23%615.00K

948.39%325.00K

-88.69%62.00K

85.92%264.00K

-89.98%43.00K

-96.50%31.00K

62.13%548.00K

-90.15%142.00K

-42.65%429.00K

86.53%886.00K

-3.70%338.00K

123.41%1.44M

61.56%748.00K

13.10%475.00K

--351.00K

--645.00K

--463.00K

--420.00K

營業費用

-13.91%3.19M

-22.43%3.21M

-21.16%3.58M

-27.88%3.36M

-16.35%3.70M

-22.90%4.14M

-2.13%4.55M

3.28%4.66M

12.02%4.43M

13.37%5.37M

1.49%4.64M

6.02%4.51M

3.08%3.95M

15.07%4.73M

41.53%4.58M

13.24%4.25M

-14.30%3.83M

25.81%4.11M

-5.27%3.23M

37.21%3.75M

93.18%4.47M

7.74%3.27M

40.73%3.41M

15.59%2.74M

9.19%2.32M

--3.04M

--2.43M

--2.37M

--2.12M

研發費用

-20.29%1.68M

-22.14%1.98M

-27.19%2.09M

-25.36%2.01M

-12.51%2.10M

-18.31%2.54M

6.46%2.87M

4.78%2.70M

14.46%2.41M

18.05%3.11M

-2.95%2.69M

-0.96%2.57M

-6.24%2.10M

20.47%2.64M

45.55%2.78M

36.72%2.60M

37.29%2.24M

64.34%2.19M

107.17%1.91M

89.72%1.90M

101.60%1.63M

-10.00%1.33M

-14.56%921.00K

-7.56%1.00M

4.92%810.00K

--1.48M

--1.08M

--772.00K

折舊攤銷及損耗

-13.93%210.00K

-10.74%216.00K

-12.55%223.00K

-12.26%229.00K

-12.86%244.00K

-14.79%242.00K

-6.25%255.00K

-1.88%261.00K

0.00%280.00K

-3.40%284.00K

-3.20%272.00K

1.92%266.00K

16.67%280.00K

31.25%294.00K

42.64%281.00K

45.81%261.00K

38.73%240.00K

34.94%224.00K

17.96%197.00K

9.82%179.00K

5.49%173.00K

-1.78%166.00K

-37.22%167.00K

24.43%163.00K

69.07%164.00K

--169.00K

--266.00K

--131.00K

--97.00K

營業利潤

-89.02%-3.12M

20.73%-3.15M

22.79%-3.51M

27.87%-3.18M

61.93%-1.65M

21.59%-3.97M

1.30%-4.54M

-177.61%-4.41M

-23.02%-4.33M

-8.38%-5.07M

-3.00%-4.60M

235.65%5.68M

6.61%-3.52M

-22.92%-4.68M

-44.41%-4.47M

-36.63%-4.18M

-137.58%-3.77M

-40.21%-3.80M

-521.53%-3.09M

-60.12%-3.06M

687.35%10.03M

-4.51%-2.71M

142.01%734.00K

-8.63%-1.91M

-11.79%-1.71M

---2.60M

---1.75M

---1.76M

---1.53M

淨非營業利息收入（費用）

利息收入

-90.82%18.00K

----

-88.89%24.00K

----

46.27%196.00K

-85.54%96.00K

-4.00%216.00K

130.59%196.00K

--134.00K

70.26%664.00K

152.81%225.00K

--85.00K

----

596.43%390.00K

32.84%89.00K

----

143.48%56.00K

--67.00K

700.00%72.00K

194.12%50.00K

--23.00K

----

-98.57%9.00K

--17.00K

----

--630.00K

----

利息費用

----

--57.00K

----

--169.00K

----

113.04%196.00K

----

1150.00%100.00K

384.21%92.00K

----

-27.27%8.00K

300.00%8.00K

375.00%19.00K

-98.67%26.00K

-99.21%11.00K

-66.67%2.00K

--4.00K

--1.95M

--1.39M

--6.00K

----

出售證券收益

----

-147.83%-285.00K

----

-379.17%-115.00K

----

87.30%-24.00K

-110.00%-42.00K

40.00%-39.00K

-27.96%67.00K

-470.59%-189.00K

48.72%-20.00K

41.44%-65.00K

113.04%93.00K

--51.00K

---39.00K

---111.00K

---713.00K

稅前利潤

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

---3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

----

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

除稅後利潤

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

---3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

----

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

持續經營利潤

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

3.76%-3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

-138.13%-3.86M

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

歸属于母公司的淨利潤

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

3.76%-3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

-138.13%-3.86M

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

歸屬普通股東的淨利潤

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

3.76%-3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

-138.13%-3.86M

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

基本每股收益

-77.72%-0.23

25.92%-0.25

27.51%-0.27

23.09%-0.28

65.39%-0.13

17.30%-0.34

1.26%-0.38

-172.52%-0.37

-11.12%-0.37

-3.94%-0.41

3.16%-0.38

231.13%0.51

8.44%-0.33

-12.02%-0.39

-34.81%-0.39

-29.78%-0.39

-129.92%-0.36

15.70%-0.35

-390.20%-0.29

-5.13%-0.30

600.53%1.20

44.73%-0.42

114.81%0.10

-5.81%-0.28

49.98%-0.24

---0.75

---0.68

---0.27

---0.48

稀釋每股收益

-77.72%-0.23

25.92%-0.25

27.51%-0.27

23.09%-0.28

65.39%-0.13

17.30%-0.34

1.26%-0.38

-175.12%-0.37

-11.12%-0.37

-3.94%-0.41

3.16%-0.38

226.58%0.49

8.44%-0.33

-12.02%-0.39

-34.81%-0.39

-29.78%-0.39

-129.92%-0.36

15.70%-0.35

-390.20%-0.29

-5.13%-0.30

600.53%1.20

44.73%-0.42

114.81%0.10

-5.81%-0.28

49.98%-0.24

---0.75

---0.68

---0.27

---0.48

每股派息

--0.00

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Collplant Biotechnologies Ltd 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 CLGN 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Collplant Biotechnologies Ltd 財年末的營收是多少？



Collplant Biotechnologies Ltd 2025 財年營收為 2.37M，高於上一財年的 515.00K。

Collplant Biotechnologies Ltd 最近一個季度的營收是多少？



Collplant Biotechnologies Ltd 最近一個季度的營收為 73.00K，同比增長 -96.45%。

Collplant Biotechnologies Ltd 全年的淨利潤是多少？



Collplant Biotechnologies Ltd 2025 財年淨利潤為 -11.49M。

Collplant Biotechnologies Ltd 上一季度的淨利潤是多少？



Collplant Biotechnologies Ltd 最近一個季度的淨利潤為 -3.10M。

Collplant Biotechnologies Ltd 年度營業利潤是多少？



Collplant Biotechnologies Ltd 2025 財年的營業利潤為 -11.35M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。